Has Jon Hillyer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $146,622 in general payments to Jon Hillyer, MD across 313 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jon Hillyer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jon Hillyer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jon Hillyer, MD

Pain Medicine · Silverdale, WANPI 1255398178

Payments from drug & device makers

$146,622in general payments, 2019–2025

Across 313 payments — averaging $468.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$127K
Vertex$14K
Nevro Corp.$1K
AbbVie$724
Boston Scientific$724
Collegium Pharmaceutical, Inc.$420
plus $3K from 38 others

What the payments were for

Speaking & faculty fees$12,44562%
Travel & lodging$8424%
Food & beverage$6,82834%
Education$750%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	74	$126,894
Vertex	14	$13,710
Nevro Corp.	34	$1,017
AbbVie(2 entities)	30	$724
Boston Scientific	12	$724
Collegium Pharmaceutical, Inc.	26	$420
Saluda Medical Americas, Inc.	4	$356
Pfizer	16	$325
Nalu Medical, Inc.	6	$227
Amgen(2 entities)	7	$204
Lilly USA, LLC	10	$181
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$144
Biohaven Pharmaceuticals, Inc.	5	$123
Abbott	5	$114
Tersera Therapeutics LLC	2	$109
Vertos Medical, Inc.	2	$100
Si-bone, Inc.	2	$89
Arbor Pharmaceuticals, Inc.	6	$82
Painteq LLC	2	$75
Teva Pharmaceuticals USA, Inc.	3	$73
Scilex Pharmaceuticals Inc.	4	$73
Bioventus LLC	2	$67
Vertiflex, Inc.	1	$64
Zyla Life Sciences, Inc.	5	$63
Daiichi Sankyo Inc.	3	$63
Bausch Health US, LLC	3	$63
Siemens Medical Solutions USA, Inc.	2	$54
Relievant Medsystems, Inc.	2	$46
Biodelivery Sciences International, Inc.	3	$45
Redhill Biopharma Inc.	2	$39
Stimwave Technologies Incorporated	1	$36
Sentynl Therapeutics, Inc.	2	$34
Pacira Therapeutics, Inc.	2	$33
Foundation Fusion Solutions, LLC	1	$33
Globus Medical	2	$32
Biotronik NRO, Inc.	1	$29
Merck	2	$28
GRT US Holding, Inc.	1	$25
Azurity Pharmaceuticals, Inc.	1	$24
Biohaven Pharmaceutical Holding Company Ltd.	1	$20
Novartis	1	$19
Alkermes, Inc.	1	$19
MDD US Operations, LLC	1	$12
Fidia Pharma USA Inc.	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

JOURNAVX$13,529
Evoke$255
SPECTRA WAVEWRITER$112
Senza Spinal Cord Stimulation System$105

How this compares

$146,622 in reported general payments places this provider in the 95th percentile of 124 pain medicine providers in Washington.

See all pain medicine providers in Washington →

Medicare billing

Part B allowed, 2024

$199,696

Medicare patients

578

Services billed

2,575

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	72	$1,607
Baclofen	11	$1,008
Pregabalin	33	$795
Morphine Sulfate ErMorphine Sulfate	20	$793
Hydromorphone Hcl	38	$788
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	24	$782
Gabapentin	37	$521
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	11	$438
Tizanidine Hcl	31	$364
Cyclobenzaprine Hcl	11	$355
Tramadol Hcl	32	$267
Meloxicam	26	$99
Carisoprodol	12	$74
Zolpidem Tartrate	14	$27

Paid to pharmacies, not to this prescriber.

Other pain medicine in Silverdale

Andrew McNeilSilverdale$6K
Deepak SreedharanSilverdale$3K
Michele CuratoloSeattle$1.6M
Miroslav BackonjaSeattle$1.3M
Jennifer LeeKirkland$1.3M
Nathan SneddonSpokane Valley$240K
Steven StanosSeattle$206K
Caroline HarstroemEverett$111K
Corrie AndersonSeattle$102K
Gregory TermanSeattle$95K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →